Laying the foundations for a robust stem cell workflow
Learn how early process decisions can improve robustness, scalability, and reproducibility in stem cell therapy development in this RegMedNet interview featuring our expert Hagen Wieland.
Moving stem cell research closer to clinical application requires workflows that are robust, scalable, and carefully controlled. Our expert joins RegMedNet to discuss how early process decisions can help researchers build more reliable stem cell therapy workflows.
From culture variability to GMP transition, scale-up, documentation, and cryopreservation, the interview explores key considerations for developing translation-ready processes.
Read the interview with RegMedNet, where our expert Hagen Wieland shares insights on:
- Building robust stem cell therapy workflows
- Reducing variability in stem cell culture systems
- Supporting GMP transition and scale-up
- Preserving stem cell functionality through cryopreservation